These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29197126)

  • 1. Anaphylactic reaction to galactose-derived oligosaccharide residues from lactose used as a drug excipient.
    Andrade ALMB; Riccetto AGL; Vilela MMDS; de Oliveira DN; Catharino RR; Nolasco da Silva MT
    Pediatr Allergy Immunol; 2018 Mar; 29(2):207-210. PubMed ID: 29197126
    [No Abstract]   [Full Text] [Related]  

  • 2. [A CASE OF ANAPHYLAXIS IN THE PEDIATRIC PATIENT WITH MILK ALLERGY DUE TO TRACES OF MILK PROTEIN IN THE LACTOSE USED AS AN EXCIPIENT OF INAVIR INHALATION].
    Morikawa M; Kanemitsu Y; Tsukamoto H; Morikawa A; Tomioka Y
    Arerugi; 2016 May; 65(3):200-5. PubMed ID: 27193929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From single excipients to dual excipient platforms in dry powder inhaler products.
    Shur J; Price R; Lewis D; Young PM; Woollam G; Singh D; Edge S
    Int J Pharm; 2016 Dec; 514(2):374-383. PubMed ID: 27262269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmaceutical drugs containing lactose can as a rule be used by persons with lactose intolerance].
    Vinther S; Rumessen JJ; Christensen M
    Ugeskr Laeger; 2015 Mar; 177(11):. PubMed ID: 25786702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lactose-containing tablets for patients with lactose intolerance?].
    Picksak G; Stichtenoth DO
    Med Monatsschr Pharm; 2009 Jan; 32(1):27-8. PubMed ID: 19205135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylactic reaction to povidone secondary to drug ingestion in a young child.
    Michavila-Gomez AV; Moreno-Palanques MA; Ferrer-Vazquez M; Ferriols-Leisart R; Bartolomé B
    Allergol Immunopathol (Madr); 2012; 40(4):259-61. PubMed ID: 21996435
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diabetic with lactose intolerance. Is there a drug without lactose?].
    Stichtenoth DO
    MMW Fortschr Med; 2010 Nov; 152(46):24; author reply 24. PubMed ID: 21229719
    [No Abstract]   [Full Text] [Related]  

  • 8. Anaphylactic shock after intravenous galactose.
    Rud C
    Lancet; 1968 Aug; 2(7566):515. PubMed ID: 4174528
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lactose-containing drugs in lactose intolerance?].
    Frey OR
    Med Monatsschr Pharm; 2002 Jan; 25(1):22. PubMed ID: 11826664
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lactose in drugs and lactose malabsorption].
    Hansen WE
    Z Gastroenterol; 1998 Mar; 36(3):XXIV-XXV. PubMed ID: 9577913
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lactose intolerance: lactose intolerant patients can they use medications that contain lactose?].
    Leuckx S
    J Pharm Belg; 2011 Sep; (3):81. PubMed ID: 21995100
    [No Abstract]   [Full Text] [Related]  

  • 12. Lactose filler as a cause of "drug-induced" diarrhea.
    Lieb J; Kazienko DJ
    N Engl J Med; 1978 Aug; 299(6):314. PubMed ID: 661937
    [No Abstract]   [Full Text] [Related]  

  • 13. Dry powders for oral inhalation free of lactose carrier particles.
    Healy AM; Amaro MI; Paluch KJ; Tajber L
    Adv Drug Deliv Rev; 2014 Aug; 75():32-52. PubMed ID: 24735676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the promoting factors of galactose and lactose metabolism in the whey. IV. Concerning substances in whey that inhibit diarrhea and consequent trophopathy developed with lactose and galactose.
    Tamura S; Tsuzuki S; Masuda M
    Jpn J Pharmacol; 1971 Feb; 21(1):107-17. PubMed ID: 5317243
    [No Abstract]   [Full Text] [Related]  

  • 15. Polymer coating of carrier excipients modify aerosol performance of adhered drugs used in dry powder inhalation therapy.
    Traini D; Scalia S; Adi H; Marangoni E; Young PM
    Int J Pharm; 2012 Nov; 438(1-2):150-9. PubMed ID: 22964399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laryngeal thrush from asthma inhalers.
    Heman-Ackah YD; Hawkshaw MJ; Lyons KM
    Ear Nose Throat J; 2012 Jan; 91(1):E24-5. PubMed ID: 22278875
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the promoting factors of galactose and lactose metabolism in the whey. 3. Concerning substances in whey that inhibit cataract developed in rats on hypergalactose and hyperlactose diets.
    Tamura S; Tsuzuki S
    Jpn J Pharmacol; 1971 Feb; 21(1):97-106. PubMed ID: 5317256
    [No Abstract]   [Full Text] [Related]  

  • 18. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
    James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
    Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of lactose and galactose in man.
    Williams CA
    Prog Biochem Pharmacol; 1986; 21():219-47. PubMed ID: 3088584
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacterial endotoxin requirements for dry powder inhalants and their excipients: are they critical quality attributes?
    Cundell AM
    PDA J Pharm Sci Technol; 2014; 68(5):386-93. PubMed ID: 25336414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.